TY  - JOUR
AB  - Considering the review by Puspitasari and colleagues, an additional discussion of the endpoints of the Se supplementation studies described would be helpful. In our view, selenium can safely be given to selenium-deficient cancer patients prior to and during radiotherapy. Therefore, in order to help the radiation oncologist in decision making, we strongly advocate to determine the selenium status prior to and during a potential adjuvant selenium supplementation, e.g. when trying to ease the side-effects of radiation treatment or in the aftercare situation when the selenium status may become insufficient.
AU  - Mücke, Ralph
AU  - Micke, Oliver
AU  - Schomburg, Lutz
AU  - Kisters, Klaus
AU  - Büntzel, Jens
AU  - Hübner, Jutta
AU  - Kriz, Jan
DA  - 2014-12-16
DO  - doi:10.1186/s13014-014-0289-0
KW  - Selenium
KW  - Supplementation
KW  - Clinical studies
KW  - Selenoproteins
KW  - Radiotherapy
LA  - eng
N1  - Radiation Oncology 9 (2014) 289, 1-2
N1  - Finanziert durch den Open-Access-Publikationsfonds 2014/2015 der Deutschen Forschungsgemeinschaft (DFG) und der Westfälischen Wilhelms-Universität Münster (WWU Münster).
PY  - 2014-12-16
SN  - 1748-717X
TI  - Selenium supplementation in radiotherapy patients: do we need to measure selenium levels in serum or blood regularly prior radiotherapy?
UR  - https://nbn-resolving.org/urn:nbn:de:hbz:6-60379584649
Y2  - 2024-11-22T12:22:10
ER  -